Pyxis Oncology, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pyxis Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Pyxis Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $3.02M, a 5.02% increase year-over-year.
  • Pyxis Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $12.4M, a 20.4% decline year-over-year.
  • Pyxis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12.9M, a 23.6% decline from 2023.
  • Pyxis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $16.9M, a 7.5% increase from 2022.
  • Pyxis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.8M, a 147% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.9M -$4M -23.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 $16.9M +$1.18M +7.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 $15.8M +$9.39M +147% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $6.37M +$6.35M +35300% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $18K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.